TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Pharmaq Analytiq AS
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
88,569
|
86,743
|
78,737 |
| Financial expenses |
359
|
544
|
486 |
| Earnings before taxes |
-5,277
|
-700
|
-6,379 |
| Total assets |
45,797
|
40,398
|
50,285 |
| Current assets |
26,034
|
18,873
|
26,763 |
| Current liabilities |
24,475
|
19,852
|
29,002 |
| Equity capital |
20,932
|
20,326
|
20,862 |
| - share capital |
1,100
|
1,100
|
1,100 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
45.7%
|
50.3%
|
41.5% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-6.0%
|
-0.8%
|
-8.1% |
| Return on assets (ROA) |
-10.7%
|
-0.4%
|
-11.7% |
| Current ratio |
106.4%
|
95.1%
|
92.3% |
| Return on equity (ROE) |
-25.2%
|
-3.4%
|
-30.6% |
| Change turnover |
1,826
|
8,006
|
-3,867 |
| Change turnover % |
2%
|
10%
|
-5% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.